The analysis revealed that in the training set, the expression of BANF1, CDK2AP2, DDT, LRIG1, MRPL4, and S100A13 was significantly upregulated in tumor samples, and the expression of EPS8, NUCB2, PAF1, PMP22, RABGAP1L, and USO1 was higher in control samples (p < 0.05) (Figure 9A). The gene discussed is S100A13; the disease is neoplasm.